Skip to main content
Clinical Trials/NCT03386760
NCT03386760CompletedPhase 1

Evaluation of an Ultra-speed Picosecond Laser for Treating Tattoos

Centre Hospitalier Universitaire de Nice1 site in 1 country18 target enrollmentStarted: January 15, 2018Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 1
Status
Completed
Enrollment
18
Locations
1
Primary Endpoint
Percentage of decrease of tattoos 2 months after the third session as compared to baseline on standardized pictures

Study Overview

Brief Summary

The investigators developed an ultra-speed picosecond laser (20ps) with a 20gHz repetition rate that provide very promising results in vitro and in ex vivo skin to remove skin tattoos.

The aim of this study is to evaluate the efficacy and tolerance of a new ultra-speed picosecond laser and to compare it to a nanosecond laser for treating black tattoos.

In a first phase of the study 10 patients with black tattoos will be treated with increasing fluencies of the picosecond laser to the optimal parameters in terms of efficacy and tolerance.

In a second phase, 10 additional subjects with black tattoos will be treated after central randomization on half of the tattoo with the picosecond laser (with the parameters determined in the first phase) and the other half treated with a nanosecond laser.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Black tattoos with surface between 10 and 100 cm²
  • •Skin type I to VI

Exclusion Criteria

  • •Childbearing age women
  • •Active dermatosis located on the tattoo
  • •Personal history of hypertrophic scars or keloids
  • •Pigmentary or vascular lesions located on the tattoo
  • •Subject taking oral steroid or retinoid or have any risk of delayed healing problems
  • •Acquired or hereditary conditions that could leead to a delayed healing
  • •Allergy to xylocaine, prilocaine or lidocaine

Arms & Interventions

A- Ultra-Speed Picosecond laser

Experimental

Utilisation of Ultra-speed Picosecond laser for tattoo depigmentation

Intervention: Laser Utilisation PicoSecond (Device)

B- Nanosecond laser

Active Comparator

Utilisation of Nanosecond laser for tattoo depigmentation

Intervention: Laser Utilisation Nano-second (Device)

Outcomes

Primary Outcomes

Percentage of decrease of tattoos 2 months after the third session as compared to baseline on standardized pictures

Time Frame: 2 month after the end of laser utilisation

Secondary Outcomes

  • Evaluation of tolerance(2 months after one session of laser utilisation)
  • satisfaction evaluation of depigmanetation tattoo(2 months after one session of laser utilisation)
  • Evaluation of Pain with EVA test(2 months after one session of laser utilisation)
  • Skin biopsies(immediately after treatment)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials